lemborexant
Drug Details
- Generic Name
- lemborexant
- Brand Names
- DAYVIGO
- Application Number
- NDA212028
- Sponsor
- Eisai Manufacturing Ltd
- NDC Codes
- 4
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- LEMBOREXANT
Indications and Usage
1 INDICATIONS AND USAGE DAYVIGO is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies ( 14.1 )] . DAYVIGO is an orexin receptor antagonist indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. ( 1 )